These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6446978)

  • 21. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Opportunistic infection in medicine: study on its causative organisms (author's transl)].
    Nasu M
    Rinsho Byori; 1979; 27(2):93-8. PubMed ID: 372637
    [No Abstract]   [Full Text] [Related]  

  • 24. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.
    Queenan AM; Shang W; Schreckenberger P; Lolans K; Bush K; Quinn J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3485-7. PubMed ID: 17005839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serratia marcescens isolated from clinical specimens in recent years].
    Nishino K; Kuze T; Kuroda C; Mizunoya T
    Rinsho Byori; 1982 Sep; 30(9):1029-32. PubMed ID: 6757494
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes effected in "Serratia marcescens" from treatment with eritrocina (author's transl)].
    Cerbo M; Vecchione R
    Ann Sclavo; 1978; 20(3):312-7. PubMed ID: 367293
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serratia in respiratory tract infection (author's transl)].
    Igari J; Kosakai N
    Kansenshogaku Zasshi; 1978 Sep; 52(9):370-7. PubMed ID: 103986
    [No Abstract]   [Full Text] [Related]  

  • 28. Outbreaks of Serratia marcescens bacteriuria in a neurosurgical intensive care unit of a tertiary care teaching hospital: a clinical, epidemiologic, and laboratory perspective.
    Yoon HJ; Choi JY; Park YS; Kim CO; Kim JM; Yong DE; Lee KW; Song YG
    Am J Infect Control; 2005 Dec; 33(10):595-601. PubMed ID: 16330308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contribution to the method of studying phagocytosis (author's transl)].
    Tichácek B
    Cesk Epidemiol Mikrobiol Imunol; 1980 Jul; 29(4):208-13. PubMed ID: 6448101
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nuclease-antibodies in infections with Serratia marcescens (author's transl)].
    Tiesler E; Hauptmann P
    Immun Infekt; 1979 Aug; 7(4):140-2. PubMed ID: 387574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infections caused by Serratia marcescens.
    Farhoudi HO
    Med Ann Dist Columbia; 1972 Oct; 41(10):617-8. PubMed ID: 4561739
    [No Abstract]   [Full Text] [Related]  

  • 32. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The virulence of Enterobacter cloacae and Serratia marcescens in experimental bladder infection in diabetic mice.
    Obana Y; Nishino T
    J Med Microbiol; 1989 Oct; 30(2):105-9. PubMed ID: 2677380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmid prevalence in antibiotic resistant Serratia marcescens.
    Llanes C; Michel-Briand Y; Bailly C; Grimont F
    J Chemother; 1989 Jul; 1(4 Suppl):311-2. PubMed ID: 16312416
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of subinhibitory levels of aminoglycosides and fluoroquinolines on hydrophobicity and motility of Serratia marcescens].
    Majtán V; Majtánová L
    Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):26-30. PubMed ID: 11233670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
    Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
    Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipopolysaccharide recovery restores susceptibility levels towards beta-lactams in Serratia marcescens.
    Palomar J; Puig M; Montilla R; Lorén JG; Viñas M
    Microbios; 1995; 82(330):21-6. PubMed ID: 7540714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous infection caused by Serratia marcescens in a child.
    García FR; Paz RC; González RS; Ruiz ES; Martín-Neda FG; Rodríguez MS; Martín MR; Sarto MS; Arguelles HA; Bustínduy MG; Cabrera AN
    J Am Acad Dermatol; 2006 Aug; 55(2):357-8. PubMed ID: 16844533
    [No Abstract]   [Full Text] [Related]  

  • 39. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid and quantitative detection of blood Serratia marcescens by a real-time PCR assay: its clinical application and evaluation in a mouse infection model.
    Iwaya A; Nakagawa S; Iwakura N; Taneike I; Kurihara M; Kuwano T; Gondaira F; Endo M; Hatakeyama K; Yamamoto T
    FEMS Microbiol Lett; 2005 Jul; 248(2):163-70. PubMed ID: 15964718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.